miRNA-499a-5p, highly enriched in EVs from metastatic lung cancer cells, modulates the mTOR pathway in recipient lung cancer cells with concomitant induction of proliferation, EMT, and migration (76). The gene discussed is MTOR; the disease is lung carcinoma.